Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.
N Engl J Med. 2013 Aug 8;369(6):507-16. doi: 10.1056/NEJMoa1306220. Epub 2013 Jun 19.
N Engl J Med. 2013.
PMID: 23782157
Free PMC article.
Clinical Trial.